Patients with the tumor predisposition syndrome NF2 present in 18-53% with spinal cord ependymomas.27 All 6 NF2 patients within our cohort, of whom DNA methylation profiles were available, were reclassified as SP-EPN. Here, NF2 is linked to BAP1-related tumor predisposition syndrome.